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Soluble fibronectin is a large glycoprotein which is found in 
blood and other body fluids. Insoluble fibronectin is found in 
connective tissues and associated with basement membranes. 
Fibronectin has been known by many other names, including 
cold-insoluble globulin, a2-surface binding opsonic protein, an-
tigelatin factor, large external transformation-sensitive (LETS) 
protein, and cell surface protein. In cell culture, fibronectin is 
secreted into the media of substrate-attached cells and depos-
ited in the extracellular connective tissue matrix. Collagen, a 
second component of the matrix, binds to fibronectin. Sulfated 
proteoglycans, heparin, hyaluronic acid, fibrin, gangliosides, 
and components of eukaryotic cell surfaces and bacterial cell 
walls also interact with fibronectin. Fibronectin has been de-
tected in very early embryos of species as distant as the chick, 
the mouse, and the sea urchin. Thus, fibronectin may have an 
organizing role in the formation ofthe extracellular matrix, may 
act as an adhesive protein for the orderly growth and positioning 
of cells, a nd may be an opsonic protein for tissue debris, soluble 
fibrin, and gram-positive bacteria. In the present review, we 
attempt to summarize the rapidly expanding literature on fi -
bronectin, particularly in relation to wound healing and tissue 
repair. A number of reviews have appeared recently which 
contain more complete references [1-5]. 
PROPERTIES OF FIBRONECTIN 
Some properties of human plasma fibronectin are given in 
t he Table. It is a fast ,B-globulin with a sedimentation coefficient 
(S~o.w) of about 13 and a molecular mass, based on sedimenta-
tion equilibrium, of 440 kilodaltons (kd). Its frictional ratio is 
about 1. 7. The properties of cell culture fibronectin are similar 
except that, as discussed below, cell culture fibronectin is 100-
fold less soluble than plasma fibronectin in physiological saline. 
Spectroscopic and hydrodynamic studies in various solvents 
suggest that both plasma and cell culture fibronectin have 
globular and flexible regions inasmuch as the sedimentation 
coefficient can change markedly in the absence of changes in 
spectroscopic properties. 
Soluble fibronectin is a disulfide-bonded dimer of 200 to 250 
kd subunits, as judged by polyacrylamide gel electrophoresis in 
sodium dodecyl sulfate with and without prior reduction. Re-
duced plasma fibronectin often migrates in these gels as 2 
closely-spaced bands of equal intensity. Fibronectin secreted or 
shed by cultured cells migrates as a diffuse band, and differences 
in the ratio of labeled carbohydrate to labeled protein can be 
shown across the band in double label experiments. Some 
laboratories have found that the apparent subunit size (in 
sodium dodecyl sulfate-polyacrylamide gels) of fibronectin se-
creted by cells in culture is slightly larger than plasma fibro-
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nectin. Fibronectin in amniotic fluid also appears to have a 
larger subunit than fibronectin in plasma. 
Insoluble fibronectin extracted from the cell layer of cultured 
cells is present as both disulfide-bonded dimers and multimers. 
Pulse labeling studies of cultured chick fibroblasts indicate that 
fibronectin is synthesized as a dimer and converts to a multimer 
with biphasic kinetics. Such studies suggest that the cysteines 
of the fibronectin dimer are oxidized in the cell layer and form 
disulfide bridges to adjacent fibronectin dimers, and that for-
mation of disulfide-bonded multimers contributes to the insol-
ubility of cell layer fibronectin under physiological conditions. 
Further studies are needed to determine whether fibronectin in 
tissue stroma is also composed of disulfide-bonded multimers. 
Disulfide-bonded multimers of fibronectin extracted from cell 
layers of normal cultured cells have the property of causing 
transformed cultured fibroblasts, which generally lack a fibro-
nectin matrix, to assume more normal morphology, to have 
increased adhesion to the substratum, and to have less cell 
surface microvilli and membrane ruffles. To do these experi-
ments, the fibronectin is solubilized in alkaline buffer and 
neutralized just prior to being added to the transformed cells. 
The added fibronectin forms a matrix which, by immunofluo-
rescence, is strikingly similar to that seen in non transformed 
cultures. Plasma fibronectin is less active than isolated cell 
layer fibronectin in restoring morphology, and reduction of cell 
layer fibronectin with dithiothreitol interferes with its ability 
to restore morphology. Thus, the disulfide-bonded fibronectin 
multin1er has biological properties which are not shared by the 
fibronectin dimer. 
MODEL OF FIBRONECTIN BASED UPON 
. PROTEOLYTIC CLEAVAGES 
Cleavage of the large polyfunctional fibronectin subunit with 
a variety of proteases results in fragments which retain one or 
more properties of the intact molecule (Fig 1). Three regions 
have been identified. The 27 kd tryptic fragment from the NH2-
terminus is basic, contains F. XIII" (plasma transglutaminase) 
reactive glutaminyl residues, binds to S. aureus and to fibrin, 
and mediates F. XIII,,-catalyzed cross-linking. to collagen. 
Strong noncovalent binding to collagen is mediated by the 
adjacent 30-60 kd region. The COOH-terminal region is respon-
sible for binding the heparin and for cell adhesive activity. The 
2 free cysteines per subunit are in the COOH-terminal one-
third of the subunit. Dimerization of the subunit is mediated 
by interchain disulfide (s) at the extreme COOH-terminus. 
INTERACTION OF FIBRONECTIN WITH FIBRINOGEN 
AND FIBRIN 
The concentration of fibronectin in serum is 20-50% less than 
the concentration in plasma; this difference is greater if clotting 
is carried out at 0-4°C. Loss of fibronectin into the clot at 22-
37°C is due to F. XIII,,-catalyzed covalent cross-linking (by E-
(y-glu tamyl) lysine linkages) between fibronectin and the a 
chain of fibrin. Loss of fibronectin into the clot at lower tem-
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TABLE 1. Properties of human plasma fibronectin 
Fast j1-globulin 
pI: 5.5-6. 2 
S~o.u ' : 12-14 S 
S ize: 440 kd 
Composed of 200 to 220 kd subunits 
Approximately 1.6 free cysteine per 200 kd subunit 
Carbohydrate content: 4 to 5% 
Concentra tion in normal adult plasma: 
male, 180-720 fLg/ ml; female, 150-540 fLg/ml 
Concen tra tion in normal serum: 20-50% less than in plasma 
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FIG 1. Model of the covalent structure of fibronectin based upon 
s tudies of proteolytic cleavage produ cts. Abbreviations: pE, pyroglu-
tamic ac id; A, alanine; M , methionine; V, valine; *Q, F. XIII,,-reactive 
glutamine; Y, ty rosine; N, asparagine; eHO, complex oligosaccharide; 
eSH, cysteine; and esse, cystine; Z, glutamic acid or glutamine. 
peratuTes is due to both noncovalent binding and covalent 
cross-linking . . The only other plasma protein known to be 
incorporated into the clot in a F . XIII,,-dependent manner is 
a 2-plasmin inhibitor. Assuming that the concentration offibrin-
ogen in plasma is 2,400 /lg/ml, of which 100% is incorporated 
into the clot; that the concentration of fibronectin in plasma is 
320 /lg/ ml, of which 35% is incorporated into the clot; and that 
the concentration of a 2-plasrnin inhibitor in plasma is 69 /lg/ml, 
of which 24% is incorporated into the clot; the mass of the clot 
would be 94.9% fibrin, 4.4% fibronectin, and 0.7% a 2-plasmin 
inhibitor. 
Fibronectin is necessary for cryoprecipitation of fibrinogen-
fibrin complexes, even when the complexes are saturated with 
fibrin. Fibronectin probably acts as a nucleus, because the ratio 
of fibronectin:fibrinogen:fibrin in the precipitated complexes is 
approximately 0.05:0.8:0.2. Such complexes are found in plasma 
of patients with "cryofibrinogenemia" and cruonic disseminated 
intravascular coagulation. Fibronectin is also necessary for the 
formation of a precipitate in heparinized plasma at 2°C. Al-
though the heparin-precipitable fraction from normal plasma 
contains about 65% fibrinogen and 35% fibronectin, the precip-
itate can be formed from plasma which lacks fibrinogen. In a 
purified system, the amount of precipitation depends upon 
fibronectin concentration, heparin concentration, pH, ionic 
strength, and calcium ion concentration. For a given set of 
conditions, the amount of precipitation is increased if fibrinogen 
is also present. Optimal precipitation OCCUl'S when fibronectin 
and heparin are present in a 3:1 '(w/w) ratio. The participation 
of fibrinogen or fibrin in the cryoprecipitation or cold heparin 
precipitation reactio.ns requires intact a chains; fibrinogen and 
fibrin molecules which lack the carboxyl terminal region of the 
a chain are excluded from these precipitates. 
Fibronectin which has been cross-linked to fibrin only subtly 
alters the properties of the clot. Fine clots (i.e., clots consisting 
of fine fibi'ils with few branch points, formed at high ionic 
strength and pH) to which fibronectin is cross-linked at 22°C 
have half the elastic modulus of cross-linked fine clots which 
lack fibronectin, whereas coru'se clots (i.e., clots consisting of 
coarse fibrils with many branch points, formed at low pH and 
ionic strength) to which fibronectin is cross-linked at 22°C have 
twice the elastic modulus of cross-linked coarse clots which lack 
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fibronectin. Cross-linking of fibronectin to fibrin, however, pro-
foundly enhances the attachment and spreading of cells on a 
fibrin-coated substratum. Thus, covalent attachment of fibro-
nectin to fibrin may be important for adhesion and migration 
of cells into a wound. 
INTERACTION OF FIBRONECTIN WITH COLLAGEN 
AND GLYCOSAMINOGL YCANS 
Fibronectin binds and can be cross-linked (by F. XIII,,) to 
several types and forms of collagen. Although there ru'e conflicts 
in the literatw'e, several generalizations seem true. First, at 4 ° 
and 20°C, fibronectin interacts better with denatUl'ed collagen 
and collagen fragments than with native collagen. Second, at 
37°C the interaction of fibronectin with native Type I collagen 
. is only at the site of cleavage of collagen by vertebrate colla-
genase. Because collagenase cleaves the al(I) chain of T ype I 
collagen in a region which lacks proline and hydroxyproline 
over a span of 12 residues, there may be local uncoiling of the 
collagen helix in this region at 37°C. Third, interstitial collagens 
(Types I, II, and III) interact better with fibronectin than 
basement membrane collagens (Types IV and V) . 
There is evidence for interactions of fibronectin with h epru'in, 
more heavily sulfated forms of heparan sulfate, hyalUl'onic acid, 
and chondroitin sulfate-containing proteoglycan. At 4°C, hep-
arin induces precipitation of plasma fibronectin into filamen-
tous structures. The fraction of heparin which is present in 
heparin-precipitated fibronectin is not enriched or depleted in 
anticoagulant activity. Heparin-precipitated fibronectin binds 
fibrinogen and native collagen. Passage of heparin or heavily 
sulfated heparan sulfate over a column of gelatin-agarose to 
which fibronectin has been previously bound strengthens the 
fibronectin-gelatin interaction. Although hyalUl'onic acid does 
not compete for binding of heparin to fibronectin, it is an 
effective inhibitor of fibronectin -heparin-induced precipitation 
of native collagen. . 
The interactions among hyaluronic acid, heparan sulfate, 
collagen, and fibronectin may be important for cell motility. 
Adhesive footpads of cu~tured cells sheared from a substratum 
are rich in fibronectin and heparan sulfate, whereas hyaluronic 
acid and chondroitin sulfate are coordinately deposited in foot-
prints left behind by cells moving over a substratum. These 
findings indicate that heparan sulfate is involved in adhesion to 
substratum, perhaps by binding to fibronectin, and that hya-
luronate-chondroitin complexes may labilize the footpad adhe-
sions, with subsequent cytoskeletal disorganization and cell 
movement. 
INTERACTION OF FIBRONECTIN WITH CELLS 
A variety of cell types adhere to fibronectin which has ad~ 
sorbed to tissue culture plastic at sites of nonspecific protein 
adsorption, to fibronectin which has specifically adsorbed to 
collagen, or to fibronectin which has been cross-linked to fibrin . 
In each of these systems, soluble fibronectin does not compete 
with adsorbed fibronectin and does not inhibit cell adhesion 
and spreading. Thus, suspended cells are unable to "arm" 
themselves with fibronectin and do not deplete the suspension 
of soluble fibronectin. The cellular "receptor" for fibronectin 
may involve a di- or tri -sialoganglioside and a ricin-binding 
glycoprotein. 
The opportunity to adhere to fibronectin seems to be very 
important for many cell types. For example, being in cuituTe . 
dishes to which fibronectin has been adsorbed allows cytoki-
nesis and growth of rat follicular cells in serum-free medium 
and migration of transformed hamster fibroblasts. Not all cell 
types requiTe fibronectin for adhesion, however [6]. Chondro-
cyte adhesion to type II collagen is stimulated by a protein 
called chondronectin, which is present in fetal serum and car-
tilage. PAM 212 epidermal cells attach preferentially to type 
IV collagen and make an adhesion factor called laminin [7). 
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INTERACTION OF FIBRONECTIN WITH BACTERIA 
Fibronectin binds specifically to Staphylococcus aureus bu t 
not to Escherichia coli or Mycobacterium butyricum. Binding 
of fibron ectin to S. aureus is only slightly inhibited by dena-
tured collagen and is not inhibited by Protein A, the immuno-
globulin binding protein of S . aureus. The nature of t he bacte-
rial component to which fibronectin binds is not known at 
present. The interaction of fibronectin with bacteria is of po-
tential importance both for the opsonization of bacteria by 
soluble fibronectin and the attachment of bacteria to insoluble 
tissue fibronectin. 
INTERACTIONS OF FIBRONECTIN WITH ACTIN AND 
DNA 
Fibronectin binds to coulumns of actin-agarose and DNA-
agarose under physiological conditions. Thus, fibronectin is one 
of the DNA-binding proteins of serum. It is not known whether 
the cellula r compartmentilization of fibronectin, ac tin, and 
DNA allows interactions to occur in whole celis. In cul tured 
cells, th e distribution of extracellular fibrone ctin and intracel-
lular actin by immunofluorescence can be remarkably similar. 
By immunoelectromicroscopy, structures containing the 2 pro-
t~ins a re separated by less than 8-22 nm across the cell m em-
brane. On the basis of these findings, a transmembrane protein 
has been postulated to link together fibronectin fibrils on the 
outside of the cell with cytoplasmic actin micromaments on the 
inside. 
SYNTHESIS AND DISTRIBUTION OF FIBRONECTIN 
IN CELL CULTURE 
Synthesis of fibronectin in cul ture has been demonstrated for 
a number of cell types, including fibroblasts, vascular endothe-
lia l cells, corneal endothelial celis, smooth muscle cells, astrog-
Iial cells, Schwann cells, glomerular cells, intestinal epithelia l 
cells, breast epithelial cells, kidney and liver epithelial cells, 
hepatocytes, chondrocytes, myoblasts, macro phages, and tera-
tocarcinoma cells. Large a moun ts of fibronectin are synthesized. 
For instance, cul tures of human embryonic fibroblasts produce 
about 120 /l-g fibronectin per mg cell protein per 24 hr. A large 
percentage (60-95%) of t he fibronectin is ra pidly secreted into 
the medium; a smaller percentage remains as trypsin-sensit ive 
extracellula r protein in the cell layer. Extracellular fibronectin 
accumulates in the cell layer of cul tured cells in patterns which 
vary from cell type to cet! type. In fibroblast cultures, the 
earliest fibronectin detectable by immunofluorescence is be-
tween t he cells and the culture dish and co-distributes with 
cytoplasmic actin micromaments. As cells grow to confluence, 
fibronectin , a long with procollagen, accumulates at sites of ceJl -
to-cell contact (Fig 2). Confluent fibroblast cul tures have an 
extracellular fibrill ar matrix which r eacts with antibodies to 
fibronectin a nd types I and III procollagen and collagen (Fig 2) 
and stains with ruthenium red, a dye which is known to bind to 
proteoglycans. When human fibroblas ts are left in cultw'e for 
several weeks or are treated with ascorbate, the fibrils become 
thicker (40-50 nm diameter rather than 10-20 nm) and ex hibi t 
67 nm periodicity when stained by an immunoperoxidase tech -
nique for fibronectin or type I procollagen and examined by 
electron microscopy (Fig 3). Fibronectin is present within the 
matrix in disulfide-bonded multimers as weJl as dimers and is 
susceptible to cross-linking by F . XIII". 
Cul t ured fibroblasts passing through mitosis lose surface -
associated fibronectin a nd then regain it as they flatten in 
telophase. Other circumstances which cause rounding of cells, 
such as transformation or treatment wit h cytochalsin B , also 
cause loss of cell surface-associated fibronectin. Loss of fibro-
nectin is presumably due to .cha nges in int racellular actin mi-
crofilaments. 
Association of cells with a fibronectin matrix has dramatic 
effects which may be of great pathophysiologic impor tance. 
Cul tured t ransformed cells acquire a more normal appearance 
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(but not normal growth cont rol) when a matrix is reconstituted 
with materia l extracted from normal cultures. Chondrocytes 
and myoblasts have fibronectin matrices in their undifferen-
tiated state. These matrices are lost when chondrocytes syn-
thesize type II collagen or myo blasts fuse a nd form myotubes. 
Differentia t ion, however, is blocked when fibronectin m atrices 
are reconstitu ted with ma t rix materia l from fibroblast cul tures. 
The labile state of the chondrocyte phenotype may be of crucia l 
importance in th e replacement of car tilage by fibrous t issue in 
rheumatoid a rthri t is and osteoarthrit is. Confluent vascular and 
corneal endothelial cells bind but do not take up low density 
lipoprotein . Fa ilure to take up low density lipoprotein by en-
docytosis has been correlated wit h acquisition of a fibron ecti n 
matrix between the endothelial ce LIs a nd substratum a nd may 
be a mechanism that prevents fatty degeneration of blood 
vessel . 
DISTRIBUTION OF FIBRONECTIN IN TISSUES 
Fibronectin can be visua lized by immunofluorescence in the 
very early embryo, and its pattern changes throughout devel-
opment. It is present in areas of cell migration, is present (a long 
with types I and III collagen) in differentiating mesenchyme, 
and is associated with limi ting membranes of fully fo rmed 
organs. It is also present in loose connective t issue. The distri-
bution of fibronectin in vivo is compatible with the distribution 
of fibronectin in cell cul ture and with fibronectin 's putative 
functions in cell ad hesion, cell migration, cell differentiation, 
and t issue stromal organization. 
Within rat a nd human sk in (8-10], fibronect in is absent from 
stable, differen t iated pa rts of t he tissue, such as sebaceous 
glands or the matrix, medulla, cortex, a nd cuticles of th e ha ir 
and the inner and outer root sheaths or the epidermis. Fibro-
nectin is fo und at sites at which cell division is occurring in 
co ntact with an extracellular scaffolding, as in the glassy mem-
brane and connective tissue sheath associated with folli cular 
epi thelium, the basem ent membrane underly ing vascular en-
dothelia l ceLIs, and the connective tissues surrounding a nd 
investing nerve and muscle fibre bundles. At the basement 
membra ne of the dennal/epidermal junction, fibronectin occurs 
at the plasma membrane of the basal cells and in the lamina 
lucida . Fibronectin is associated with collagen fibers in derm al 
connective t issues and is pre ent within the endoplasmic r etic-
ulum of dermal fibroblasts. 
During experimental wound healing (ll] and granuloma for-
ma tion (1 2], fibronectin is presen t in large amounts in fibrin 
clots a nd in the regene rating tissue matrix . A marked increase 
in fibronectin is found in the deep dermis of involved sclero-
derma skin in pa rallel with the increase in collagen (13,14]. In 
affected skin in systemic a nd systemic lupus erythematosus, 
there a re changes in the distribution of fibronectin in the 
demlal/ep iden nal ' junction and in the papillary dermis (15]. 
T here are fibronectin-negative gaps and sli t formation in the 
dermal/epidermal region , togeth er with fibronectin-positive 
globu la r bod ies and transport of fibronectin into the epidermis. 
FIBRONECTIN AS AN OPSONIN 
Following injection of phagocytic material, the phagocytic 
system is refracto ry for s~veral hours to cha llenge by a second 
phagocytic stimulus. The depression in phagocytic activity is 
due, at least in pa rt, to depletion of fibronectin . Animals with 
low fibronectin concent ration do not clear gelatin-coated par-
t icles as quickly as animals wi th normal fibronectin concentra-
tions, .a nd serum with low fibronectin concentration does n()t 
support the heparin-dependent binding of gelatin-coated par-
t icles to liver slices. P lasma fib ronectin, whether measured by 
the liver slice assay or a n immunologic assay, is decreased in 
patients fo llowing major surgery or major trauma and in se-
verely ill patien ts wi th evidence of dissemina ted intravasculaJ" 
coagulation. D epression of fibronectin occurs in R hesus mon-
keys with Rocky Mountain spotted fever and in a number of 
178 MOSHER AND FURCHT Vol. 77, No.2 
-
a b 
f 
FIG 2. Loca lization of type I procollagen and fibro nectin on young cultured human skin fibroblasts. a, E lectron micrograph of type I 
procollagen localization on ve ry low density human fibroblasts. Very small amou nts of procollagen type I localization product are presen t on t he 
surfaces of noncontacting ce lls. Occasiona lly small discrete patches of procollagen are seen (arrows); however, most membrane sw-faces a.re free 
of staining (x 3,800). b, Electron micrograph of fibronectin localization on very low density human fibroblasts. Patches of nonfibrillar fibronec tin 
a.re present on the plasmalemma of most ce lls (a.rrows). The extens ive vesicles seen in high dens ity cul tures a re not presen t (x 5,500) . c, E lectron 
micrograph of heavy metal counte rs tained t hin section of young confluen t human fibroblasts. The extracell ular fibrillar matrix (F) has developed. 
The fibrils are L5-25 nm in diameter and lack periodicity. Many vesicles (V) a re presen t near t he plasma membrane which is difficu lt to discern 
because it is sectioned tangentia lly parallel to the monolayer (x 6,800). d, Ultrastru ctura l localization of procollagen type I on young conf1uent 
human fibrob lasts . Type I procollagen is presen t on bundles of extracellula r fibri ls as well as in a diffuse form on the plasma membrane and in 
membrane-associated vesicles. The tangentia lly sectioned membrane is more easily discerned in t h IS micrograph, since it is coated with t he 
diffuse form of loca lization product (bel ween facing a.rrows) (x 6,700) . e, Ultrastructura l loca li zation of fibronectin on the surface of young 
confl uent human fibroblasts . Fibronectin is present on the extracellula r fibrilla r matrix, in a diffuse form on the plasma membrane and a lso in 
membrane-associated vesicles (seen bes t in Fig 3e and other sections grazing t he membrane) (x 5,500). f, E lectron micrograph of adsorption 
con trol fo r fibroncctin localization. No staining is present when ant.ifibronectin is preadsorbed with purified fibronectin ( x 3,800). 
other experimental models. However, depression of reticulo-
endothelial system phagocytic activi ty may be seen with normal 
cil·culating fibronectin concentration , as after endotoxin injec-
t ions in rats. 
Changes in plasma fibronectin concentration are not com-
monly assoc iated with severe diseases. Fibronectin is not an 
active phase reactant following myocardial infarction . Fibro-
nee tin concentration varies amo ng individuals, a nd females 
tend to have lower concentrations than males. Fibronectin 
concentration is normal in pregnant women, but the concentra-
tion can increase several-fold in recurrent cholestasis of preg-
na ncy. Newborns have 35% of the normal ad ul t plasma concen-
tration of fibronectin . Fibronecti"n is a lso present in amniotic 
fluid and cereb rospinal fluid . 
T he plasma concentration of fibronectin is probably de-
creased in seve rely ill patients with disseminated intravascular 
coagulation because of increased utilization' rather than de-
creased synthesis. Experimental d isseminated intravascular co-
agulation iI;! rabbits causes decreases of both 12r'I-fibronectin 
a nd 1:Il I-fibrinogen; decreases in '2"I-fibronectin are ·not found in 
animals initially defibrinated with pit viper venom. These find-
ings indicate that fibronectin complexes with fibrin formed by 
t hrombin, but not by pit viper venom, and t hat t he complexes 
are rapidly cleared from the blood. Fibronectin may mediate 
t he clearance of soluble fibrin by macrophages. 
The concentration of plasma fibronectin that is requ ired for 
normal function is not known. Patients with less than 50% of 
the normal concentration (150 I-tg/ml or less) have a higher 
mortality than pa tients with normal concentrations. Decreases 
in fibronectin concentration are strongly associated with de-
creases in the concentrations of plasminogen and a ,-an t ithrom-
bin, and it may be premature to attribute mortality in a defi-
ciency of fibronectin. Restoration of fibronectin concentration 
by giving cryoprecipitate, however, has had sometimes dramatic 
effects on pu lmonary function, limb blood flow, and overall 
clinical well-being in an ongoing tria l. 
FIBRONECTIN, PLATELETS, AND ENDOTHELIAL 
CELLS 
P latelets contain 2-4 I-tg or fibronectin per 10" plate lets or 
about 0.5% of the blood's conten t of fibronectin. P latelet fibro-
nectin is assoc iated with a granules and is released when 
platelets a re stimulated with thrombin or collagen. Upon stim-
ulation of washed platelets, fibronectin can be demonstrated by 
imJ11unof1u orescence on the platelet surface. When washed 
platelets a re allowed to adhere to collagen a nd then sonicated, 
platelet proteins remaining attached to collagen after sonication 
are enriched in fibronectin and cytoskeletal proteins. Preincu-
bation of collagen with plasma fibronectin at 22°C blocks the 
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FI G 3. Effect of extended t ime in culture on type I procollagen and fibron ectin distribu tion in cultures of human skin fibroblasts as vi ualized 
by light. a nd electron microscopy. n, Young confluent cu ltures of human fibrob lasts (one week old) have 11 fibrilla r d istribu tion of type I 
procollagen which surrounds fibroblasts. A rrows indicate 3 examples of fibri llar staining (x 200). b, Young confluent cullures of human fibroblasts 
have a fibronectin distribution which closely resembles that seen for t.ype I proco llagen (x 200). c, Old cul tures of human fib rob lasts (l mo old) 
have long lacy arrays of fibr ils which stain for procollagen type I (X 200). d, Old cultu res of hLiman fibroblasts ( 1 mo old) develop a dense matrix 
of fibronectin which appears to span between cells (arrowhead). A fa int staining of the lacy fibrils (as seen in 3c) is a lso present (small Q./TOWS) 
(x 200). e, By electron microscopy, type I procoLlagen in 1 mo old cul tu re is present in fibrils which have the characteristic morpho logy of mature 
collagen fibrils (see insert) . The fibrils have a 67 nm axial periodicity and are quite long, coursing in a fashion parallel to the fibrob lasts. St.aining 
fo r type I procollagen is a lso present in a diffuse manner on the plasmalemma (arrows) and in membrane-associat.eri vesicles (x 5,000, insert X 
15,000). (, By electron microscopy, fibronectin in 1 mo old cu ltures coats membrane surfaces as short fibrils wh ich extend perpendicula rly from 
the surface (arrowheads). Other membrane surfaces have the diffuse sta ining characterist ic of confluen t cul tu res. Vesicular staining is present. 
Longer fibrils are stained, some of which have 67 nm axial periodicity (insert) . In other micrographs. the longer, periodic fibrils are more prevalent 
(x 5,000, insert x ·15,000). 
ability of the collage n to induce re lease of serotonin from 
washed platelets. These findings su ggest a pathway in w hich 
fibronectin is secreted from p latelets, binds to the platelet 
surface, a nd m ediates collagen-platelet a dhesion a nd further 
stimulation of p latelets by collagen. However, preincubation of 
washed platelets with gelatin only s ligh t ly reduces t he binding 
of p latelets to collagen in a' quantitative adhesion assay, a nd 
t h e seque nce of the region of the a l(III) chain of type III 
colJage n whic h is most active in platelet a dh esion does not 
r esemble t h e sequence abou t th e collagenase cleavage site of 
type I collagen w hich is recognized by plasma fibronectin . 
Further, plasma fibronectin enha nces rathe r th a n inhib its 
spread ing of p latelets on collagen-coated su rfaces. F ina lly ; a 
fa mily with E hlers-Danlos syndrom e has been described in 
which p latelet aggregatio n by collagen is enh anced when puri-
fied p lasm a fibronectin is added t.o t he patient's p latelet-ric h 
plasma [16]. These findings seem to rule ou t any s imple mod e l 
in which cell surface fibronectin is a "receptor" for collagen but 
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suggest t hat t he pools of fib ronectin in platelets, plasma, and 
vessel wa ll somehow are importa nt in pla telet reactions. 
SUMMARY OF THE POSSIBLE PHYSIOLOGIC AND 
P AT HOPHYSIOLOGIC ACTIONS OF FIBRONECTIN 
Fibronectin has a bewildering number of interactions and 
possible functions. During and a fter the final stage of blood 
coagulation, it probably mediates the cleara nce of soluble fibrin 
that escapes the area of clotting, is covalently cross-linked to 
the clot, supports cell growth and migra tion into the clot, 
pa rticipates in the elaboration of the extracellular matrix that 
will replace the clot, a nd mediates the growth and migra tion of 
cells within the ma tr ix as it evolves. Fibronectin proba bly plays 
similar important roles during embryogenesis. In addition, fi-
bronectin may opsonize gram positive bacteria and debris in 
devitalized t issues, may mediate the a ttachment of bacteria to 
da maged t issues, and may help media te the activa tion of plate-
lets by damaged t iss\les. Some severely ill patients have de-
creased plasma concentrations of fibronec tin. Thus, the increas-
ing in fo rmation a bout fibron ectin has given new insights into 
t he adhesive properties of cells and a bet ter unders tanding of 
wound healing a nd tissue repair. 
REFERENCES 
l. M osesson MW, Amra ni DL: The structure a nd biologic activi t ies 
of plasma fi br onec tin. Blood 56:145-158, 1980. 
2. Mosher OF: Fibronectin, Progress in He mostasis and Thrombo is, 
vo l V. Edi ted by TH S paet. New York , Grune-Stratton, 1980, pp 
111 - 15 1 . 
J Pea rlste in E, Gold Ll, Garcia-Pa rdo A: Fibronec tin: A review of its 
structure a nd biological activity. Mol Cell Biochem 29:103- 128, 
1980 
4. Wart iovaara J , Leivo I , Va heri A: Matrix glycoproteins in early 
Vol. 77, No.2 
mouse developme nt a nd in diffen 'n t iation of teratocar cinom a 
ce lls, The Cell Surface: Mediato r of D evelopmental P rocesses. 
Edited by S S ubtelny, NK W essells. N ew York , Adademic P ress, 
1980, pp 305- 324 
5. Yamada KM , Olden K: Fibronectins-Adhesive glycoproteins of 
ce ll surface a nd blood . N a ture 275:1 79-184, 1978 
6. Federgreen W , Stenn K S: Fibronectin (LETS) does not support 
epi t he lia l ce ll spreading. J Invest Denna tol 75:261-263, 1980 
7. T erra nova VP, Rohrbach DH, M ar t in GR: Role of laminin in th e 
a ttachmen t of PAM 212 (epithelia l) cells to basement membra ne 
co llagen. Cell , 22: 719-726, 1980 
8. Stenma n S , Va heri A: Distribu t ion of a major connective tissue 
protein, f1bronectin, in normal huma n tissues. J Exp M ed 147: 
1054-1064, 1978 
9. Fyra nd 0: Studies on fibronectin in the skin. !. Indirec t immuno-
fluorescence studies in normal human skin . Br J Dermato l 101: 
263- 270, 1979 
10 . Couchma n JR, Gibson WT, Th orn 0 , W eaver AC, R ees DA, P arish 
WE: Fibronectin distribution in epi thelial a nd associated tissues 
of t he rat. Arch D erma tol R es 266:295-310, 1979 
11. G rinne ll F, Bi ll ingha m RE, Burgess L: Distribution of fibronectin 
during wound healing in vivo. J Invest D ermatol, 76:181- 189, 
1981 
12. Kurkine n M , Vaheri A, R oberts PJ , Stenma n S : Sequ en t ia l a p-
peara nce of fibronectin a nd collagen in experimenta l granula tion 
t issue. La b Invest 43:47-51, 1980 
13. Cooper S M , Keyser AJ, Beau lieu AD, Ruoslah ti E , Nimni ME, 
Quismorio, Jr FP: Increase in libronec tin in the deep dermis of 
involved skin in progressive systemic sclerosis. Arth Rheum 22: 
983-987, 1979 
14. Fleischmajer R , Dessau W, Timpl R, Krieg T , Luderschmid t C, 
Wiestner M: Immunofluorescence a na lysis of collagen, f1bronec-
tin , and basement membra ne protein in scleroderma skin. J 
Invest Dermatol 75:270-274, 1980 
15. Fyra nd 0: Studies on libronectin in the skin: Indir ect immunoflu o-
rescence studies in lupus erythema tosis. Br J D ermatol 102: [67-
171, 1980 
16. Arneson MA, Hammerschmidt DE, Furch t LT, King RA: A new 
form of Ehlers-D a nlos syndl·ome. JAMA 244:144-147, 1980 
